COVID-19 (Coronavirus) Update: Testing and Information | Vaccine Updates | Visitor Guidelines

GILEAD-5F9009-MDS: ENHANCE: A Randomized, Double-blind, Multicenter Study Comparing Magrolimab in Combination with Azacitidine versus Azacitidine Plus Placebo in Treatment-naïve Patients with Higher Risk MDS

Protocol No
FORTYSEVEN-5F9009-MDS
Principal Investigator
Guru Subramanian Guru Murthy
Phase
III
Summary
The purpose of this study is to compare the effects, both good and bad, of magrolimab in combination with azacitidine, to those of azacitidine in combination with placebo, to find out which is better for treating patients with MDS.
Description
Magrolimab + Azacitidine versus Azacitidine + Placebo in Untreated MDS
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL